Effect of nitric oxide on calcium-activated potassium channels in colonic smooth muscle of rabbits

G Lu1, B Mazet, M G Sarr

  • 1Department of Physiology and Biophysics, Mayo Clinic, Rochester, Minnesota 55905, USA.

Insights

Nitric oxide (NO) activates potassium calcium-activated (KCa) channels in rabbit colon smooth muscle. This process occurs via a cyclic guanosine monophosphate (cGMP) pathway, leading to smooth muscle hyperpolarization.

Area of Science:

  • Physiology
  • Gastroenterology
  • Molecular Biology

Background:

  • Nitric oxide (NO) is known to hyperpolarize intestinal smooth muscle cells.
  • The precise mechanism by which NO influences KCa channels in the colon remains to be fully elucidated.

Purpose of the Study:

  • To determine the mechanism by which nitric oxide (NO) activates KCa channels in circular smooth muscle of the rabbit colon.
  • To investigate the role of cyclic guanosine monophosphate (cGMP) in NO-mediated KCa channel activation.

Main Methods:

  • NADPH-diaphorase staining to identify nerve fibers in rabbit colon transmural biopsies.
  • Whole-cell, on-cell, and excised inside-out patch clamp electrophysiology to monitor KCa current and channel activity.
  • Pharmacological agents including charybdotoxin, methylene blue, cystamine, 8-bromo-cGMP, and zaprinast were used.

Main Results:

  • NO increased whole-cell outward current by 79% and hyperpolarized smooth muscle cells.
  • NO increased the open probability (NPo) of KCa channels in on-cell patches, an effect blocked by charybdotoxin.
  • NO's effect on NPo was diminished by cGMP pathway inhibitors (methylene blue, cystamine) and mimicked by a cGMP analog (8-BrcGMP) and phosphodiesterase inhibitor (zaprinast).

Conclusions:

  • Nitric oxide activates KCa channels in rabbit colon circular smooth muscle.
  • This activation is mediated through a cGMP-dependent pathway.
  • NO-induced KCa channel activity contributes to the hyperpolarization of intestinal smooth muscle.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Smooth Muscle Contraction01:25

Smooth Muscle Contraction

Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Feedback Regulation of Calcium Concentration01:27

Feedback Regulation of Calcium Concentration

Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...